Tag Archives: PhRMA

Typhoon Trauma: The Pharma Score on Disaster Relief

Big Pharma is quietly stepping up to provide critical supplies of essential medicines, other health equipment, and skilled local personnel to areas of the Philippines devastated by Typhoon Haiyan this month.  Although industry operations in the Philippines appear largely intact, most companies are working through global humanitarian aid organizations due to the logistical challenges created […]
Posted in Corporate Responsibility, Emerging Markets, Global | Also tagged , , , , , , | Leave a comment

Pharma's Transparency Troubles

Transparency Troubles for Pharma High prices, murky financial relations, and a reluctance to disclose clinical data are undermining public trust in industry and the research enterprise, writes Jill Wechsler It seems like open season on the pharmaceutical industry. Academics and consumer activists charge pharma companies with hiding clinical trial information on medical product safety, fueling […]
Posted in Europe, FDA, Guest Blog, Op-Ed, Regulatory | Also tagged , , , , | Leave a comment

PhRMA Research and Hope Awards Gives Industry a Shot in the Arm

Vaccines–once the neglected also ran in big Pharma’s armamentarium of innovations–received top billing at PhRMA’s annual Research and Hope awards held at the Washington Newseum on September 11.  More than 200 industry executives, politicians and scientists recognized the accomplishments of three separate teams in developing and building access to  preventive vaccines.
Posted in Events, healthcare, R&D | Also tagged , , , , , , , , , , , | Leave a comment

PhRMA Dismayed by Global IPR Report

Posted in Global, Guest Blog, IP, Regulatory | Also tagged , , | Leave a comment

PCORI Launches Clinical Research Network to Support Trials, Outcomes Research

The new National Patient-Centered Clinical Research Network funded by the Patient-Centered Outcomes Research Institute (PCORI) aims to provide patients and clinicians with useful information on treatment options and outcomes. By encouraging more comparative clinical effectiveness research (CER),  the program also has potential to support development of new drugs and devices, explained PCORI executive director Joe […]
Posted in FDA, healthcare | Also tagged , , , , , , , , , , , , , | Leave a comment
  • Categories

  • Meta